YIDU TECH's Affiliate Secures Contract for Tianjin Cancer Hospital's Intelligent Clinical Research Platform

Stock News
05/21

YIDU TECH (02158) announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has recently been awarded the contract for the Intelligent Clinical Research Integrated Platform Construction Project at Tianjin Cancer Hospital. The total project value is approximately RMB 7.39 million.

YIDU TECH is a core driver of intelligent transformation within China's healthcare system. The company deeply empowers the entire industry chain encompassing "healthcare, pharmaceuticals, insurance, and patients" through intelligent decision-making, aiming to make precision medicine accessible to everyone.

By simulating clinical decision-making logic, using real disease progression as training data, and undergoing continuous real-world validation, the company has developed an "AI that truly understands disease." This provides measurable value to key segments of the medical ecosystem: equipping doctors with more precise and efficient decision-making tools, helping pharmaceutical companies shorten the distance from molecule to patient, enabling patients to access more affordable precision diagnosis and treatment, and providing public health systems with more scientific support.

YIDU TECH leverages its proprietary, system-level intelligence to create a more resilient, compassionate, inclusive, and efficient future for healthcare.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10